Composite prodrug nanocarrier and preparation method for reversing tumor drug resistance
A nanocarrier, prodrug technology, applied in the fields of polymer materials and medical engineering, can solve the problems of tissue side effects, drug leakage, high risk of non-targeted hyperthermia and chemotherapy synergy, etc.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0028]Those 100 mg of polymethyl methacrylate-polyethylene glycol copolymer reacts it with 20 mg of carboxylated tetravalent platinum to obtain macromolecular prodrugs attached by ester bond and tetrametin, poly (methyl) Acrylic - tetravalent platinum) - polyethylene glycol, wherein the coupling ratio of hydroxypropyl propyl polymethyl methacrylate and carboxylate is 90%.
[0029]Take 5 mg of particle diameter of 8 nm super-metallomagnetic nanoparticles MNFE2O4And 5 mg of platinum macromolecular prodrug poly (hydroxypropate - tetravalent platinum) - polyethylene glycol, dispersed in a mixed solution of 2 mL of tetrahydrofuran / NN-dimethylformamide = 1 / 1, then The mixed solution was added to 20x volume of deionized water under ultrasound, and then the organic solvent obtained the aqueous solution of the composite prior art diometric nanocarrier in deionized water. Then, the composite prior art nano carrier was lyophilized to obtain a powder solid. (Such asfigure 1The process flow diagr...
Embodiment 2
[0031]80 mg of poly N-hydroxymethyl acrylamide-polyethylene glycol copolymer, the hydroxyl group of the polyn-hydroxymethylacrylamide is used to form a combination amine, then react with a 20 mg hydrochloride, obtained by 腙 腙Macromolecular prodrug connection of doxorubicin, poly (n-methacrylate hydroxyethyl methacrylate) - polyethylene glycol, wherein the modified polyn-methyl methacrylate is an ethyl ester with doxorubicin. The association is 86%.
[0032]Take 2mg of superfluent magnetic nanoparticles Mn having a particle size of 15 nm0.6Zn0.4FE2O4And 5 mg macromolecular prodrug (N-hydroxymethylacrylamide-doxorubicin)-polyethylene glycol, add 5 mL of tetrahydrofuran / dimethyl sulfoxide = 1 / 1 mixed solution, then in ultrasound The mixed solution was added to the mixed solution, and then in deionized water was dialyzed in deionized water, the organic solvent was removed from the aqueous solution of the composite prior art nano-carrier. Then, the composite prior art nano carrier was lyo...
Embodiment 3
[0034]10 mg of polymethyl methacrylate-polyethylene glycol copolymer, react with 10 mg of methotrexate to obtain macromolecular prodrugs connected to methotrexate, poly (methyl) Harrative hydroxypropyl acrylate - methotrexate - polyethylene glycol, wherein the coupling ratio of hydroxyethyl methacrylate and methotrexate is 88%.
[0035]Take 2 mg of superfluent magnetic nanoparticles Mn having a particle size of 12 nm0.4Zn0.6FE2O4And 4 mg macromolecular prodrug poly (hydroxypropate-methotrexate)-polyethylene glycol, mixed solution of 4 mL of tetrahydrofuran / NN-dimethylformamide = 3 / 7, then Under ultrasound, the mixed solution was added to 20x volume of deionized water, and then dialyzed in deionized water for 24 hours, the organic solvent was removed to obtain aqueous solution of the composite prior art diometric nanocarrier. Then, the composite prior art nano carrier was lyophilized to obtain a powder solid. This product was dispersed in water at a lower concentration (0.1 mg / mL) i...
PUM
Property | Measurement | Unit |
---|---|---|
particle diameter | aaaaa | aaaaa |
particle diameter | aaaaa | aaaaa |
particle diameter | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com